Skip to main content
Top
Published in: Clinical and Experimental Nephrology 2/2012

01-04-2012 | Case Report

A case of acute renal failure after exercise with renal hypouricemia demonstrated compound heterozygous mutations of uric acid transporter 1

Authors: Ayami Ochi, Takashi Takei, Akiko Ichikawa, Chiari Kojima, Takahito Moriyama, Mitsuyo Itabashi, Toshio Mochizuki, Atsuo Taniguchi, Kosaku Nitta

Published in: Clinical and Experimental Nephrology | Issue 2/2012

Login to get access

Abstract

Familial renal hypouricemia is a hereditary disease characterized by extraordinary high renal uric acid (UA) clearance and is associated with acute renal failure (ARF). A 17-year-old Japanese male developed ARF after anerobic exercise. Renal function improved completely after approximately 2 weeks of hydration treatment. After remission, hypouricemia became evident (1.0 mg/dL) from the initial level of UA (4.8 mg/dL) and fractional excretion of uric acid (FEUA) was >50%. His parents showed normal levels of UA and FEUA. Polymerase chain reaction of a urate anion exchanger known to regulate UA level [SLC22A12 gene: UA transporter 1 (URAT1)] demonstrated compound heterozygous mutations (Q297X and R90H). Thus, we describe a Japanese male with hypouricemia complicated by anerobic exercise-induced ARF, with definite demonstration of a genetic abnormality in the responsible gene, URAT1.
Literature
1.
go back to reference Erley CM, Hirschberg RR, Hoefer W, et al. Acute renal failure due to uric acid nephropathy in a patient with renal hypouricemia. Klin Wochenschr. 1989;67:308–12.PubMedCrossRef Erley CM, Hirschberg RR, Hoefer W, et al. Acute renal failure due to uric acid nephropathy in a patient with renal hypouricemia. Klin Wochenschr. 1989;67:308–12.PubMedCrossRef
2.
go back to reference Ohta T, Sakano T, Ogawa T, et al. Exercise-induced acute renal failure with renal hypouricemia: a case report and a review of the literature. Clin Nephrol. 2002;58:313–6.PubMed Ohta T, Sakano T, Ogawa T, et al. Exercise-induced acute renal failure with renal hypouricemia: a case report and a review of the literature. Clin Nephrol. 2002;58:313–6.PubMed
3.
go back to reference Uribarri J, Oh MS. Renal hypouricemia and absorptive hypercalciuria: a real syndrome. Nephron. 1993;63(2):172–5.PubMedCrossRef Uribarri J, Oh MS. Renal hypouricemia and absorptive hypercalciuria: a real syndrome. Nephron. 1993;63(2):172–5.PubMedCrossRef
4.
go back to reference Ishikawa I. Acute renal failure with severe loin pain and patchy renal ischemia after anaerobic exercise in patients with or without renal hypouricemia. Nephron. 2002;91:559–70.PubMedCrossRef Ishikawa I. Acute renal failure with severe loin pain and patchy renal ischemia after anaerobic exercise in patients with or without renal hypouricemia. Nephron. 2002;91:559–70.PubMedCrossRef
5.
go back to reference Igarashi T, Sekine T, Sugimura H, et al. Acute renal failure after exercise in a child with renal hypouricaemia. Pediatr Nephrol. 1993;7:292–3.PubMedCrossRef Igarashi T, Sekine T, Sugimura H, et al. Acute renal failure after exercise in a child with renal hypouricaemia. Pediatr Nephrol. 1993;7:292–3.PubMedCrossRef
6.
go back to reference Hisanaga S, Kawamura M, Uchida T, et al. Exercise-induced renal failure in a patient with hyperuricosuric hypouricemia. Nephron. 1994;66:475–6.PubMedCrossRef Hisanaga S, Kawamura M, Uchida T, et al. Exercise-induced renal failure in a patient with hyperuricosuric hypouricemia. Nephron. 1994;66:475–6.PubMedCrossRef
7.
go back to reference Enomoto A, Wempe MF, Tsuchida H, et al. Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition. J Biol Chem. 2002;277:36262–71.PubMedCrossRef Enomoto A, Wempe MF, Tsuchida H, et al. Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition. J Biol Chem. 2002;277:36262–71.PubMedCrossRef
8.
go back to reference Ichida K, Hosoyamada M, Hisatome I, et al. Clinical and molecular analysis of patients with renal hypouricemia in Japan—influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol. 2004;15:164–73.PubMedCrossRef Ichida K, Hosoyamada M, Hisatome I, et al. Clinical and molecular analysis of patients with renal hypouricemia in Japan—influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol. 2004;15:164–73.PubMedCrossRef
9.
go back to reference Matsuo H, Chiba T, Nagamori S, Nakayama A, Domoto H, Phetdee K, Wiriyasermkul P, Kikuchi Y, Oda T, Nishiyama J, Nakamura T, Morimoto Y, Kamakura K, Sakurai Y, Nonoyama S, Kanai Y, Shinomiya N. Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am J Hum Genet. 2008;83(6):744–51.PubMedCrossRef Matsuo H, Chiba T, Nagamori S, Nakayama A, Domoto H, Phetdee K, Wiriyasermkul P, Kikuchi Y, Oda T, Nishiyama J, Nakamura T, Morimoto Y, Kamakura K, Sakurai Y, Nonoyama S, Kanai Y, Shinomiya N. Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am J Hum Genet. 2008;83(6):744–51.PubMedCrossRef
10.
go back to reference Van Peenen HJ. Causes of hypouricemia. Ann Intern Med. 1973;78:977–8.PubMed Van Peenen HJ. Causes of hypouricemia. Ann Intern Med. 1973;78:977–8.PubMed
11.
go back to reference Hisatome I, Ogino K, Kotake H, Ishiko R, Saito M, Hasegawa J, Mashiba H, Nakamoto S. Cause of persistent hypouricemia in outpatients. Nephron. 1989;51:13–6.PubMedCrossRef Hisatome I, Ogino K, Kotake H, Ishiko R, Saito M, Hasegawa J, Mashiba H, Nakamoto S. Cause of persistent hypouricemia in outpatients. Nephron. 1989;51:13–6.PubMedCrossRef
12.
go back to reference Komoda F, Sekine T, Inatomi J, Enomoto A, Endou H, Ota T, Matsuyama T, Ogata T, Ikeda M, Awazu M, Muroya K, Kamimaki I, Igarashi T. The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia. Pediatr Nephrol. 2004;19:728–33.PubMedCrossRef Komoda F, Sekine T, Inatomi J, Enomoto A, Endou H, Ota T, Matsuyama T, Ogata T, Ikeda M, Awazu M, Muroya K, Kamimaki I, Igarashi T. The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia. Pediatr Nephrol. 2004;19:728–33.PubMedCrossRef
13.
go back to reference Iwai N, Mino Y, Hosoyamada M, Tago N, Kokubo Y, Endou H. A high prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese. Kidney Int. 2004;66:935–94.PubMedCrossRef Iwai N, Mino Y, Hosoyamada M, Tago N, Kokubo Y, Endou H. A high prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese. Kidney Int. 2004;66:935–94.PubMedCrossRef
14.
go back to reference Yeun JY, Hasbargen JA. Renal hypouricemia: prevention of exercise-induced acute renal failure and a review of the literature. Am J Kidney Dis. 1995;25:937–46.PubMedCrossRef Yeun JY, Hasbargen JA. Renal hypouricemia: prevention of exercise-induced acute renal failure and a review of the literature. Am J Kidney Dis. 1995;25:937–46.PubMedCrossRef
15.
go back to reference Murakami T, Kawakami H, Fukuda M, Shiigi H. Recurrence of acute renal failure and renal hypouricemia. Pediatr Nephrol. 1993;7:772–3.PubMedCrossRef Murakami T, Kawakami H, Fukuda M, Shiigi H. Recurrence of acute renal failure and renal hypouricemia. Pediatr Nephrol. 1993;7:772–3.PubMedCrossRef
Metadata
Title
A case of acute renal failure after exercise with renal hypouricemia demonstrated compound heterozygous mutations of uric acid transporter 1
Authors
Ayami Ochi
Takashi Takei
Akiko Ichikawa
Chiari Kojima
Takahito Moriyama
Mitsuyo Itabashi
Toshio Mochizuki
Atsuo Taniguchi
Kosaku Nitta
Publication date
01-04-2012
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 2/2012
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-011-0557-3

Other articles of this Issue 2/2012

Clinical and Experimental Nephrology 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.